A new treatment for gonorrhea shows promise, which is welcome news with global rates of the sexually transmitted infection on the rise and antibiotic resistance becoming more prevalent.

Gonorrhea has developed resistance to nearly all the antibiotics used for its treatment, according to the CDC. If left untreated, gonorrhea can lead to serious health complications, including ...

Debiopharm initially received funding from CARB-X in 2017 for pre-clinical development of Debio1453, which inhibits an ...

Gonorrhea, and other sexually transmitted infections, are becoming more difficult to treat as they become increasingly more resistant to existing antibiotics. The CDC currently recommends ...

A world-first vaccine for gonorrhoea is being rolled out in England after the number of cases hit record highs. The number of ...

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow's standard-of-care to cure cancer and infectious diseases, is honored to share that ...

The OxStu discusses the causes and implications of antimicrobial resistance, and the social and scientific methods to combat ...

ENGLAND will roll out the world’s first gonorrhoea vaccine campaign this summer. The NHS said it will begin immunising ...

England will be the first country to offer a gonorrhoea vaccine to high-risk groups, as cases hit record highs and resistance ...